Practice Areas & Industries: Stradling Yocca Carlson & Rauth A Professional Corporation

 





Group Profile Lawyers in this Group Offices Locations for this Group
 

Practice/Industry Group Overview

The 21st Century has been labeled the "Century of Biology" for the promise that biological research and innovation hold to improve human health and quality of life. Our Life Science practice group counsels the companies driving this technological revolution. We provide sophisticated counsel to medical device, pharmaceutical, and biotechnology companies at all stages of development, from early-stage entrepreneurial ventures through mature, NYSE-traded global enterprises.

Stradling Yocca Carlson & Rauth was selected as one of California’s leading life sciences law firms for the past four years by Chambers & Partners, the premier ranking source for law firms and attorneys.

We apply our 30-plus years of corporate experience to the legal needs of our life science industry clients in areas such as company formation, venture capital and other private financing, debt and lease financing, public offerings, securities law, executive compensation and employee incentive plans, and mergers and acquisitions. With our employment law group we advise on employment issues of our life science clients. We also work closely with our litigation group in the event of disputes involving those clients, counseling to seek alternatives to litigation where appropriate, or assisting in the prosecution or defense of claims.

In addition, we specialize in advising on all types of technology transfer, including supply, OEM, distribution and license arrangements, joint ventures, and strategic alliances. Our life science practice group, often working with our intellectual property, securities and tax attorneys, guides our clients through the complex process of structuring, negotiating, and documenting these transactions for the exploitation of their technology, both in the United States and worldwide. Using the same expertise, we advise our clients on the acquisition of technology from inventors, academic and research institutions, and commercial sources.